作者: J. W. Kendig , R. H. Notter , J. M. Davis , A. Bartoletti , H. S. Dweck
DOI: 10.1007/978-3-642-73305-5_12
关键词:
摘要: This paper is concerned with the clinical therapy of lung disease, particularly treatment pathology which involves a functional deficiency (quantitative or qualitative) pulmonary surfactant. As many other kinds medical therapies, however, efficacy surfactant-deficient disease has increased directly understanding underlying pathophysiology. Thus, although aspects are stressed, discussion initiated by considering some basic concepts surfactant (LS) and its influence on physiology.